Insider Selling: Arteris, Inc. (NASDAQ:AIP) VP Sells $28,194.11 in Stock

Arteris, Inc. (NASDAQ:AIP) VP Paul L. Alpern sold 2,471 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $11.41, for a total value of $28,194.11. Following the completion of the transaction, the vice president now owns 64,930 shares in the company, valued at $740,851.30. The trade was a 3.67 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Arteris Price Performance

Shares of Arteris stock traded up $0.03 during midday trading on Monday, hitting $12.28. 495,407 shares of the company traded hands, compared to its average volume of 869,555. The stock has a market cap of $493.37 million, a price-to-earnings ratio of -12.79 and a beta of 1.17. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. The firm’s fifty day moving average price is $9.00 and its 200-day moving average price is $8.08. Arteris, Inc. has a 12 month low of $4.83 and a 12 month high of $12.64.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AIP. US Bancorp DE bought a new stake in Arteris during the 3rd quarter worth $34,000. The Manufacturers Life Insurance Company bought a new stake in shares of Arteris during the second quarter worth about $86,000. Algert Global LLC acquired a new position in shares of Arteris in the second quarter valued at approximately $115,000. MetLife Investment Management LLC raised its holdings in Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after buying an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new stake in Arteris during the 3rd quarter worth approximately $226,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities reaffirmed a “buy” rating and issued a $15.00 target price on shares of Arteris in a report on Wednesday, November 6th.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.